Correction to: Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes (Diabetologia, 10.1007/s00125-017-4426-9);Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes

Diabetologia

Volumn 60, Issue 12, 2017, Pages 2352-2360

  Keser, Toma ^a   Gornik, Ivan ^b   Vučković, Frano ^c   Selak, Najda ^a   Pavić, Tamara ^a   Lukić, Edita ^b   Gudelj, Ivan ^c   Gašparović, Hrvoje ^b   Biočina, Bojan ^b   Tilin, Therese ^d   Wennerström, Annika ^e   Männistö, Satu ^e   Salomaa, Veikko ^e   Havulinna, Aki ^e   Wang, Wei ^f,g   Wilson, James F ^h   Charutvedi, Nishi ^d   Perola, Markus ^e   Campbell, Harry ^h   Lauc, Gordan ^a,c   Gornik, Olga ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f EDITH COWAN UNIVERSITY   (Australia)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes predisposition; Hyperglycaemia; N linked glycans; Plasma N glycome; Type 2 diabetes

Indexed keywords

GLUCOSE; GLYCAN; HEMOGLOBIN A1C; N GLYCOME; PLASMA PROTEIN; SUGAR; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN; POLYSACCHARIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHEMICAL MODIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DIABETOGENESIS; FEMALE; GALACTOSYLATION; GLUCOSE BLOOD LEVEL; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYPERGLYCEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIALYLATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; GLYCOSYLATION; METABOLISM; MIDDLE AGED; PREGNANCY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCATED HEMOGLOBIN A; GLYCOSYLATION; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; POLYSACCHARIDES; PREGNANCY; YOUNG ADULT;

EID: 85029456112     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4515-9     Document Type: Erratum

References (23)

1. International Diabetes Federation (IDF). IDF diabetes Atlas 7th edition. idf.org. 2015. Available from http://www.diabetesatlas.org. Accessed 15 June 2016
2. Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 25:263–269
3. Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus. Acta Diabetol 47(Suppl 1):29–33
4. Gornik O, Pavic T, Lauc G (2012) Alternative glycosylation modulates function of IgG and other proteins—implications on evolution and disease. Biochim Biophys Acta 1820:1318–1326
5. Lauc G, Rudan I, Campbell H, Rudd PM (2010) Complex genetic regulation of protein glycosylation. Mol BioSyst 6:329–335
6. Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, Lauc G (2009) Stability of N-glycan profiles in human plasma. Glycobiology 19:1547–1553
7. Drake PM, Cho W, Li B et al (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56:223–236
8. Testa R, Vanhooren V, Bonfigli AR et al (2015) N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. PLoS One 10:e0119983
9. Itoh N, Sakaue S, Nakagawa H et al (2007) Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes. Am J Physiol Endocrinol Metab 293:E1069–E1077
10. Higai K, Azuma Y, Aoki Y, Matsumoto K (2003) Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus. Clin Chim Acta 329:117–125
11. Vartiainen E, Laatikainen T, Peltonen M et al (2010) Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39:504–518
12. McQuillan R, Leutenegger AL, Abdel-Rahman R et al (2008) Runs of homozygosity in European populations. Am J Hum Genet 83:359–372
13. Tillin T, Forouhi NG, McKeigue PM, Chaturvedi N (2012) Southall and Brent REvisited: cohort profile of SABRE, a UK population-based comparison of cardiovascular disease and diabetes in people of European, Indian Asian and African Caribbean origins. Int J Epidemiol 41:33–42
14. Huffman JE, Pucic-Bakovic M, Klaric L et al (2014) Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13:1598–1610
15. Saldova R, Asadi Shehni A, Haakensen VD et al (2014) Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. J Proteome Res 13:2314–2327
16. Ohtsubo K, Chen MZ, Olefsky JM, Marth JD (2011) Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 17:1067–1075
17. Johswich A, Longuet C, Pawling J et al (2014) N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway. J Biol Chem 289:15927–15941
18. Miyahara K, Nouso K, Saito S et al (2013) Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis. PLoS One 8:e74861
19. Sarrats A, Saldova R, Pla E et al (2010) Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl 4:432–448
20. Pawlowski T, Mackiewicz A, Mackiewicz S (1986) Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A. Behring Inst Mitt 80:11–15
21. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428
22. Otvos JD, Shalaurova I, Wolak-Dinsmore J et al (2015) GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem 61:714–723
23. Akinkuolie AO, Pradhan AD, Buring JE, Ridker PM, Mora S (2015) Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 35:1544–1550